Track & Trace – And Delay: Pharmacies Get Enforcement Discretion From FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's grace period for transaction information sharing means that distribution channels will operate more smoothly, but also could result in more missed deadlines down the road.
You may also be interested in...
Track And Trace Deadline Could Slip Again After Worries Over Inferencing
Generic representative raises concerns about errors from bulk scanning, while distributors and pharmacies feel failure to include inferencing will hinder patient access to drugs.
Drug Shortages Mostly FDA’s Fault, House Oversight Committee Concludes
Report says aggressive enforcement in recent years has forced capacity offline, which led to shortages.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.